Pacific Biosciences

$15.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.89 (+6.12%) Today

+$0.54 (+3.50%) As of 4:54 AM EST after-hours

Why Robinhood?

You can buy or sell PACB and other stocks, options, and ETFs commission-free!

About PACB

Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA. The listed name for PACB is Pacific Biosciences of California, Inc. Common Stock.

CEO

Christian O. Henry

Employees

404

Headquarters

Menlo Park, California

Founded

2000

Market Cap

2.89B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.78M

High Today

$15.63

Low Today

$14.45

Open Price

$14.61

Volume

2.33M

52 Week High

$17.14

52 Week Low

$2.20

Collections

PACB Earnings

-$0.20

-$0.13

-$0.06

$0.01

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 4, After Hours